The public float for ADVB is 3.28M and currently, short sellers hold a 0.08% ratio of that float. The average trading volume of ADVB on May 12, 2025 was 146.98K shares.
ADVB) stock’s latest price update
The stock of Advanced Biomed Inc (NASDAQ: ADVB) has decreased by -11.32 when compared to last closing price of 1.07.Despite this, the company has seen a loss of -51.34% in its stock price over the last five trading days. globenewswire.com reported 2025-03-07 that Tainan, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) — Advanced Biomed Inc. (the “Company”) (NASDAQ: ADVB), a biotechnology company focused on early screening and detection, diagnosis and staging, and treatment of cancer, today announced the closing of its initial public offering (the “Offering”) of 1,640,000 shares of common stock (the “Shares”), at a public offering price of $4.00 per share for total gross proceeds of $6.56 million before deducting underwriting discounts and offering expenses. The Shares began trading on the Nasdaq Capital Market on March 6, 2025 under the ticker symbol “ADVB.”
ADVB’s Market Performance
The volatility ratio for the week is 37.25% while the volatility levels for the last 30 days are 22.26% for Advanced Biomed Inc The simple moving average for the past 20 days is -46.71% for ADVB’s stock, with a -65.49% simple moving average for the past 200 days.
ADVB Trading at -65.49% from the 50-Day Moving Average
After a stumble in the market that brought ADVB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.86% of loss for the given period.
Volatility was left at 22.26%, however, over the last 30 days, the volatility rate increased by 37.25%, as shares sank -47.28% for the moving average over the last 20 days.
During the last 5 trading sessions, ADVB fell by -51.34%, in comparison to the 20-day moving average, which settled at $1.7805. In addition, Advanced Biomed Inc saw -74.00% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ADVB
The total capital return value is set at -3.07.
Based on Advanced Biomed Inc (ADVB), the company’s capital structure generated 0.32 points at debt to capital in total, while cash flow to debt ratio is standing at -8.32.
Currently, EBITDA for the company is -2.14 million with net debt to EBITDA at 1.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.82.
Conclusion
In conclusion, Advanced Biomed Inc (ADVB) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
